The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...
ScienceAlert on MSN
Multiple Sclerosis May Have Two Distinct Subtypes, Scientists Discover
There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...
A woman living with multiple sclerosis (MS) has shared how she has found joy through pottery. Sarah Reeve, from Tunbridge ...
Cold weather can significantly worsen multiple sclerosis symptoms, triggering stiffness, fatigue, and reduced mobility.
Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...
NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...
A new University of Toronto-led study has discovered a possible biomarker linked to multiple sclerosis (MS) disease ...
Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...
This surgery is ideal for patients who may be deemed inoperable or at high risk for open heart surgery. For patients like Ms.
NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with ...
GlobalData on MSN
Biogen’s Tysabri to be used on England’s NHS for highly active MS
NICE has recommended Tysabri and biosimilar Tyruko as an option for patients with highly active relapsing-remitting multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results